Connect your AI

Integra LifeSciences IART Price / book

Price / book at other companies

Becton, Dickinson and CompanyBDX

1.9×-0.8×

AxogenAXGN

7×-0.8×

Globus MedicalGMED

2.5×0.0×

AbbVieABBV

261×+221×

MedtronicMDT

2.1×-0.1×

STERISSTE

3×-0.4×

Other financials

Income statement

Revenue$391.9M+2.4%

Gross profit$217.0M+11.6%

Operating income$11.5M+174%

Net income-$4.6M+81.7%

EPS (diluted)-$0.06+81.8%

Balance sheet

Cash & equivalents$236.8M-1.0%

Total debt$2.0B+3.2%

Total equity$1.0B-31.6%

Total assets$3.6B-11.7%

Cash flow

Operating cash flow$9.8M+187%

CapEx$14.8M-48.7%

Free cash flow-$5.0M+87.4%

Valuation

Market cap$1.38B+53.4%

Enterprise value$3.12B+21.1%

P/S0.8×+0.3×

Profitability

Gross margin51.9%-1.6pp

Operating margin-29.8%-30.3pp

Net margin-30.1%—

FCF margin3.8%-6.3pp

Returns & leverage

Return on equity-38.6%—

Debt / equity1.9×+0.6×

Current ratio3.4×+2.2×

Where this comes from

Calculated from Integra LifeSciences’s reported figures.

market cap/total stockholders equity=0.7×

Based on the most recent quarter.

The official record: Integra LifeSciences’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Integra LifeSciences's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Integra LifeSciences's price / book?: Integra LifeSciences (IART) reported price / book of 0.7× in Q1 2026.
How has Integra LifeSciences's price / book changed year-over-year?: Integra LifeSciences's price / book decreased by 36.8% year-over-year, from 1.1× to 0.7×.
What is the long-term trend for Integra LifeSciences's price / book?: Over 5 years (2020 to 2025), Integra LifeSciences's price / book has grown at a -23.9% compound annual growth rate (CAGR), from 3.6× to 0.9×.
What does price / book mean?: Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.